Global X Genomics & Biotechnology ETF
GNOM
3 hedge funds and large institutions have $415K invested in Global X Genomics & Biotechnology ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2.24% more ownership
Funds ownership: 0% → 2.24% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$359K |
| 2 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$13.8K |
| 3 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$9.28K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $381K | +$359K | +6,304 | New |
|
|
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $24K | +$13.8K | +243 | New |
|
|
BFEC
3
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $10K | +$9.28K | +163 | New |
|
GNOM Hedge Fund Activity: Q2 2019 in Review
3 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2019, worth a combined $415K.
Buyers outnumbered sellers: 3 funds opened new GNOM positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $359K.
- 3 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $415K of Global X Genomics & Biotechnology ETF stock for Q2 2019.
- 3 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2019 and 0 closed out, a net change of +3 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2019 was Jane Street, an estimated $359K added.
Based on aggregated 13F filings for Q2 2019.